Research Overview

Retatrutide (LY3437943) is a novel triple-acting agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies.

Specifications

Form: Lyophilized powder
Storage: Store the powder refrigerated (2–8°C) or frozen, protected from light and moisture, until the printed expiry. After reconstitution, keep refrigerated (do not freeze); full potency ~1 month, with a noticeable quality drop after ~6 weeks.

For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.

Certificate of Analysis (Janoshik)

Independent third-party testing by Janoshik Analytical. Click to view full report.

Retatrutide 10mg Certificate of Analysis — Retatrutide 10mg — Janoshik Analytical

Retatrutide 20mg Certificate of Analysis — Retatrutide 20mg — Janoshik Analytical

Retatrutide 30mg Certificate of Analysis — Retatrutide 30mg — Janoshik Analytical

Shop